The top line is rapidly becoming “top of mind” as companies try to seize the growth opportunities of a rebounding economy. It’s no surprise that an analysis of Fortune 500 companies over the last decade confirms that growth is the key to shareholder value. At our organization, Revenue Enhancement is about making money— this quarter. Our approach focuses on increasing cash flow while holding down associated Selling, General & Administrative (SG&A) costs, streamlining processes and improving performance across all of your marketing, sales and service activities.
|
Revenue Management for Life Sciences
|
